These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36172196)

  • 1. Patient-led development of digital endpoints and the use of computer vision analysis in assessment of motor function in rare diseases.
    Ferrer-Mallol E; Matthews C; Stoodley M; Gaeta A; George E; Reuben E; Johnson A; Davies EH
    Front Pharmacol; 2022; 13():916714. PubMed ID: 36172196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases.
    Servais L; Camino E; Clement A; McDonald CM; Lukawy J; Lowes LP; Eggenspieler D; Cerreta F; Strijbos P
    Digit Biomark; 2021; 5(2):183-190. PubMed ID: 34723071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home-based video assessment of ease of movement for patients with Duchenne: Interviews with physical therapists to select movement tasks.
    Contesse MG; Hodges J; Staunton H; Lowes LP; Elmankabadi B; Elder SJ; Ormazabal MG; Dalle Pazze L; Leffler MG
    Physiother Res Int; 2023 Jan; ():e1993. PubMed ID: 36718112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Reliability of the Functional Evaluation Scale for Duchenne Muscular Dystrophy, Gait Domain: A Pilot Study.
    de Carvalho EV; Hukuda ME; Escorcio R; Voos MC; Caromano FA
    Physiother Res Int; 2015 Sep; 20(3):135-46. PubMed ID: 25521365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with L-citrulline and metformin in Duchenne muscular dystrophy: study protocol for a single-centre, randomised, placebo-controlled trial.
    Hafner P; Bonati U; Rubino D; Gocheva V; Zumbrunn T; Gueven N; Fischer D
    Trials; 2016 Aug; 17(1):389. PubMed ID: 27488051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory and upper limb function as outcome measures in ambulant and non-ambulant subjects with Duchenne muscular dystrophy: A prospective multicentre study.
    Ricotti V; Selby V; Ridout D; Domingos J; Decostre V; Mayhew A; Eagle M; Butler J; Guglieri M; Van der Holst M; Jansen M; Verschuuren JJGM; de Groot IJM; Niks EH; Servais L; Straub V; Voit T; Hogrel JY; Muntoni F
    Neuromuscul Disord; 2019 Apr; 29(4):261-268. PubMed ID: 30852071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Combination l-Citrulline and Metformin Treatment on Motor Function in Patients With Duchenne Muscular Dystrophy: A Randomized Clinical Trial.
    Hafner P; Bonati U; Klein A; Rubino D; Gocheva V; Schmidt S; Schroeder J; Bernert G; Laugel V; Steinlin M; Capone A; Gloor M; Bieri O; Hemkens LG; Speich B; Zumbrunn T; Gueven N; Fischer D
    JAMA Netw Open; 2019 Oct; 2(10):e1914171. PubMed ID: 31664444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Extremity Functional Outcome Measures in Duchenne Muscular Dystrophy-A Delphi Survey.
    Senesac CR; Lott DJ; Willcocks RJ; Duong T; Smith BK
    J Neuromuscul Dis; 2019; 6(1):75-83. PubMed ID: 30562905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
    Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
    Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Duchenne Video Assessment scorecards to evaluate ease of movement among those with Duchenne muscular dystrophy.
    Contesse MG; Lowes LP; White MK; Dalle Pazze L; McSherry C; Alfano LN; Iammarino M; Reash N; Bonarrigo K; Kiefer M; Laubscher K; McIntyre M; Mockler S; Nelson L; Vogel L; Leffler MG
    PLoS One; 2022; 17(4):e0266845. PubMed ID: 35417501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory muscle training in children and adults with neuromuscular disease.
    Silva IS; Pedrosa R; Azevedo IG; Forbes AM; Fregonezi GA; Dourado Junior ME; Lima SR; Ferreira GM
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD011711. PubMed ID: 31487757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is It Possible to Have Home E-Monitoring of Pulmonary Function in Our Patients with Duchenne Muscular Dystrophy in the COVID-19 Pandemic?-A One Center Pilot Study.
    Wasilewska E; Sobierajska-Rek A; Małgorzewicz S; Soliński M; Szalewska D; Jassem E
    Int J Environ Res Public Health; 2021 Aug; 18(17):. PubMed ID: 34501557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy.
    Bendixen RM; Lott DJ; Senesac C; Mathur S; Vandenborne K
    Disabil Rehabil; 2014; 36(22):1918-23. PubMed ID: 24499260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preserved thenar muscles in non-ambulant Duchenne muscular dystrophy patients.
    Naarding KJ; Keene KR; Sardjoe Mishre ASD; Veeger TTJ; van de Velde NM; Prins AJ; Burakiewicz J; Verschuuren JJGM; van der Holst M; Niks EH; Kan HE
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):694-703. PubMed ID: 33963807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation.
    Hind D; Parkin J; Whitworth V; Rex S; Young T; Hampson L; Sheehan J; Maguire C; Cantrill H; Scott E; Epps H; Main M; Geary M; McMurchie H; Pallant L; Woods D; Freeman J; Lee E; Eagle M; Willis T; Muntoni F; Baxter P
    Health Technol Assess; 2017 May; 21(27):1-120. PubMed ID: 28627356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy.
    Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD
    J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adapting traditional content validation methods to fit purpose: an example with a novel video assessment and training materials in Duchenne muscular dystrophy (DMD).
    White MK; Leffler M; Rychlec K; Jones C; McSherry C; Walker L; Kosinski M
    Qual Life Res; 2019 Nov; 28(11):2979-2988. PubMed ID: 31302840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digital PCR quantification of miR-30c and miR-181a as serum biomarkers for Duchenne muscular dystrophy.
    Llano-Diez M; Ortez CI; Gay JA; Álvarez-Cabado L; Jou C; Medina J; Nascimento A; Jimenez-Mallebrera C
    Neuromuscul Disord; 2017 Jan; 27(1):15-23. PubMed ID: 27979502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials.
    Ricotti V; Evans MR; Sinclair CD; Butler JW; Ridout DA; Hogrel JY; Emira A; Morrow JM; Reilly MM; Hanna MG; Janiczek RL; Matthews PM; Yousry TA; Muntoni F; Thornton JS
    PLoS One; 2016; 11(9):e0162542. PubMed ID: 27649492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
    Bourke JP; Bueser T; Quinlivan R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.